680 related articles for article (PubMed ID: 18221819)
1. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.
Popov Y; Patsenker E; Stickel F; Zaks J; Bhaskar KR; Niedobitek G; Kolb A; Friess H; Schuppan D
J Hepatol; 2008 Mar; 48(3):453-64. PubMed ID: 18221819
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.
Patsenker E; Popov Y; Stickel F; Jonczyk A; Goodman SL; Schuppan D
Gastroenterology; 2008 Aug; 135(2):660-70. PubMed ID: 18538673
[TBL] [Abstract][Full Text] [Related]
3. Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes.
Popov Y; Patsenker E; Fickert P; Trauner M; Schuppan D
J Hepatol; 2005 Dec; 43(6):1045-54. PubMed ID: 16223543
[TBL] [Abstract][Full Text] [Related]
4. Role of integrin αvβ6 in the pathogenesis of ischemia-related biliary fibrosis after liver transplantation.
Chen G; Zhang L; Chen L; Wang H; Zhang Y; Bie P
Transplantation; 2013 May; 95(9):1092-9. PubMed ID: 23422496
[TBL] [Abstract][Full Text] [Related]
5. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
6. Integrin alphavbeta6 and mediators of extracellular matrix deposition are up-regulated in experimental biliary atresia.
Nadler EP; Patterson D; Violette S; Weinreb P; Lewis M; Magid MS; Greco MA
J Surg Res; 2009 Jun; 154(1):21-9. PubMed ID: 19084240
[TBL] [Abstract][Full Text] [Related]
7. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.
Patsenker E; Wilkens L; Banz V; Osterreicher CH; Weimann R; Eisele S; Keogh A; Stroka D; Zimmermann A; Stickel F
J Hepatol; 2010 Mar; 52(3):362-9. PubMed ID: 20137822
[TBL] [Abstract][Full Text] [Related]
8. Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice.
Yoshida S; Ikenaga N; Liu SB; Peng ZW; Chung J; Sverdlov DY; Miyamoto M; Kim YO; Ogawa S; Arch RH; Schuppan D; Popov Y
Gastroenterology; 2014 Dec; 147(6):1378-92. PubMed ID: 25173753
[TBL] [Abstract][Full Text] [Related]
9. Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis.
Neef M; Ledermann M; Saegesser H; Schneider V; Reichen J
J Hepatol; 2006 Dec; 45(6):786-96. PubMed ID: 17050028
[TBL] [Abstract][Full Text] [Related]
10. Expression of extracellular matrix genes in cultured hepatic oval cells: an origin of hepatic stellate cells through transforming growth factor beta?
Wang P; Liu T; Cong M; Wu X; Bai Y; Yin C; An W; Wang B; Jia J; You H
Liver Int; 2009 Apr; 29(4):575-84. PubMed ID: 19323784
[TBL] [Abstract][Full Text] [Related]
11. Combination of systemic thioacetamide (TAA) injections and ethanol feeding accelerates hepatic fibrosis in C3H/He mice and is associated with intrahepatic up regulation of MMP-2, VEGF and ICAM-1.
Kornek M; Raskopf E; Guetgemann I; Ocker M; Gerceker S; Gonzalez-Carmona MA; Rabe C; Sauerbruch T; Schmitz V
J Hepatol; 2006 Sep; 45(3):370-6. PubMed ID: 16780996
[TBL] [Abstract][Full Text] [Related]
12. Role of alphavbeta6 integrin in acute biliary fibrosis.
Wang B; Dolinski BM; Kikuchi N; Leone DR; Peters MG; Weinreb PH; Violette SM; Bissell DM
Hepatology; 2007 Nov; 46(5):1404-12. PubMed ID: 17924447
[TBL] [Abstract][Full Text] [Related]
13. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse.
Canbay A; Feldstein A; Baskin-Bey E; Bronk SF; Gores GJ
J Pharmacol Exp Ther; 2004 Mar; 308(3):1191-6. PubMed ID: 14617689
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats.
Paik YH; Kim JK; Lee JI; Kang SH; Kim DY; An SH; Lee SJ; Lee DK; Han KH; Chon CY; Lee SI; Lee KS; Brenner DA
Gut; 2009 Nov; 58(11):1517-27. PubMed ID: 19201774
[TBL] [Abstract][Full Text] [Related]
15. Expression of Bax, Bcl-xL and Bcl-2 proteins in relation to grade of inflammation and stage of fibrosis in chronic hepatitis C.
Piekarska A; Kubiak R; Omulecka A; Szymczak W; Piekarski J
Histopathology; 2007 Jun; 50(7):928-35. PubMed ID: 17543083
[TBL] [Abstract][Full Text] [Related]
16. The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats.
Yu J; Hui AY; Chu ES; Go MY; Cheung KF; Wu CW; Chan HL; Sung JJ
Liver Int; 2009 Jan; 29(1):25-36. PubMed ID: 18435714
[TBL] [Abstract][Full Text] [Related]
17. Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat.
Iimuro Y; Nishio T; Morimoto T; Nitta T; Stefanovic B; Choi SK; Brenner DA; Yamaoka Y
Gastroenterology; 2003 Feb; 124(2):445-58. PubMed ID: 12557150
[TBL] [Abstract][Full Text] [Related]
18. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats.
Boigk G; Stroedter L; Herbst H; Waldschmidt J; Riecken EO; Schuppan D
Hepatology; 1997 Sep; 26(3):643-9. PubMed ID: 9303494
[TBL] [Abstract][Full Text] [Related]
19. Connective tissue growth factor and integrin αvβ6: a new pair of regulators critical for ductular reaction and biliary fibrosis in mice.
Pi L; Robinson PM; Jorgensen M; Oh SH; Brown AR; Weinreb PH; Trinh TL; Yianni P; Liu C; Leask A; Violette SM; Scott EW; Schultz GS; Petersen BE
Hepatology; 2015 Feb; 61(2):678-91. PubMed ID: 25203810
[TBL] [Abstract][Full Text] [Related]
20. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.
Isayama F; Hines IN; Kremer M; Milton RJ; Byrd CL; Perry AW; McKim SE; Parsons C; Rippe RA; Wheeler MD
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1318-28. PubMed ID: 16439470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
